status: 200
encoding: ISO-8859-1
Cache-Control: private
Content-Type: text/html
Server: Microsoft-IIS/8.5
X-Powered-By: ASP.NET
Date: Fri, 03 May 2019 20:22:18 GMT
Content-Length: 107525

<html lang="en"> 
<!-- Trigger/Open The Modal -->
<div style="position: fixed; z-index: 999; top: 5; left: 600; background-color: navy; display: block">
<button id="myBtn" style="color: white; background-color: navy; display: block">Translate Website</button></div>
<!-- The Modal -->
<div id="myModal" class="modal" style="display: none">
  <!-- Modal content -->
  <div class="modal-content">
      <div class="modal-header"><h3>
    <span class="close">&times;</span></h3></div>    
    <p>The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.</p>
    <p>Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.</p>
    <p>The English language version is always the official and authoritative version of this website.</p>
    <p>NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.</p>  
      <div style="text-align: center">Powered by <span style="white-space: nowrap"><a class="goog-logo-link" href="https://translate.google.com" target="_blank"><img width="37" height="14" style="padding-right: 3px;" alt="Google Translate" src="https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_42x16dp.png">Translate</a></span></div>
             <div style="text-align: center" id="google_translate_element"></div><br /><br />             
       <div class="modal-footer">
          <h4></h4>
      </div>
  </div>
</div>    

<script type="text/javascript">
    function googleTranslateWidgetInit() {
        new google.translate.TranslateElement({ pageLanguage: 'en', layout: google.translate.TranslateElement.InlineLayout.SIMPLE, autoDisplay: false }, 'google_translate_element');
    }
</script><script type="text/javascript" src="//translate.google.com/translate_a/element.js?cb=googleTranslateWidgetInit"></script> 
<script type="text/javascript">
    // Get the modal
    var modal = document.getElementById('myModal');
    // Get the button that opens the modal
    var btn = document.getElementById("myBtn");
    // Get the <span> element that closes the modal
    var span = document.getElementsByClassName("close")[0];
    // When the user clicks on the button, open the modal 
    btn.onclick = function () {
        modal.style.display = "block";
    }
    // When the user clicks on <span> (x), close the modal
    span.onclick = function () {
        modal.style.display = "none";
    }
    // When the user clicks anywhere outside of the modal, close it
    window.onclick = function (event) {
        if (event.target == modal) {
            modal.style.display = "none";
        }
    }
</script>

<div id = "divBackground" style="position: fixed; z-index: 999; height: 100%; width: 100%; top: 0; left:0; background-color: Black; filter: alpha(opacity=60); opacity: 0.6; -moz-opacity: 0.8;display:none">
</div>

<head>

<link rel="stylesheet" type="text/css" href="/style/lis.css">
<link rel="stylesheet" type="text/css" media="print" href="/style/print.css">
<link rel="GILS" href="http://info.er.usgs.gov/public/gils/gilsexec.html">
<link rel="Shortcut Icon" HREF="/LISlogo1.ico">
<SCRIPT LANGUAGE="JavaScript" TYPE="text/javascript">
<!--

if(window.event + "" == "undefined") event = null;
function HM_f_PopUp(){return false};
function HM_f_PopDown(){return false};
popUp = HM_f_PopUp;
popDown = HM_f_PopDown;

//-->
</SCRIPT>
  
<!--
    option explicit
  -->
<meta http-equiv="PICS-Label" content='(PICS-1.1 "http://www.weburbia.com/safe/ratings.htm" l r (s 0))'>
<meta name="classification" content="Government">
<meta name="distribution" content="Global">
<meta name="rating" content="General">
<meta name="contactState" content="IL">
<meta name="siteTitle" content="Illinois General Assembly">
<meta name="keywords" content="Illinois General Assembly, legislation, house bills, house resolutions, senate bills, senate resolutions, amendments">
<meta name="description" content="Legislation listing for the Illinois General Assembly">
<meta name="createDate" content="4/17/2002">
<meta name="dateofLastModification" content="4/17/2002">
<meta name="timePeriodTextual" content="2001-2002">
<meta name="originalControlIdentifier" content="0000001">
<meta name="medium" content="Web Site">
<meta name="PermanentPublicAccess" content="yes">
<meta name="agencyProgram" content="Illinois General Assembly">
<meta name="linkage" content="">
<meta name="language" content="EN">
<meta name="govType" content="State">
<meta name="contactName" content="Legislative Information System">
<meta name="contactOrganization" content="LIS Staff Services">
<meta name="contactStreetAddress1" content="705 Stratton Office Building">
<meta name="contactStreetAddress2" content="">
<meta name="contactCity" content="Springfield">
<meta name="contactZipcode" content="62706">
<meta name="contactNetworkAddress" content="webmaster@ilga.gov">
<meta name="contactPhoneNumber" content="217-782-3944">
<meta name="contactFaxNumber" content="217-524-6059">
<meta name="originatorJurisdiction" content="State Of Illinois">
<meta name="originatorOffice" content="Illinois General Assembly">
<meta name="originatorDepartment" content="Legislative Information System">
<meta name="originatorDivision" content="Web Staff">
<meta name="originatorSection" content="">
<meta name="Classification" content="Government--State Government--Illinois General Assembly">

<title>Illinois General Assembly - Full Text of HB0156</title>
</head>

<!-- Begin Body Start -->


<body ONLOAD="document.NumString.NumSearch.focus();"  bgcolor="#FFFFFF" text="#000000" link="#3366FF" vlink="#663366" alink="#9933FF" topmargin="0" leftmargin="0">
<script LANGUAGE="JavaScript1.2" SRC="/include/script/HM_Loader.js" TYPE="text/javascript"></script>

<table align="left" border="0" width="100%" cellpadding="0" cellspacing="0">
<tr id="Legislation">
    <td colspan="4"><a href="/default.asp"><img border="0" src="/images/logo_sm.gif" alt="Illinois General Assembly" width="462" height="49"></a>
    </td>
    </tr>
    <tr>
      <td colspan="4" valign="top" align="left">
        <table class="mainmenu" border="0" width="100%" cellspacing="0">
<tr id="Legislation">
            <td height="25" nowrap>&nbsp;&nbsp;<a class="mainmenu" href="/">Home</a>&nbsp;&nbsp;</td>
            <td height="25" nowrap>&nbsp;&nbsp;<a class="mainmenu" onMouseOver="HM_f_PopUp('elMenu1',event)" onMouseOut="HM_f_PopDown('elMenu1')" onfocus="HM_f_PopUp('elMenu1',event)" onblur="HM_f_PopDown('elMenu1')" href="/legislation/">Legislation &amp; Laws</a>&nbsp;&nbsp;</td>
            <td height="25" nowrap>&nbsp;&nbsp;<a class="mainmenu" onMouseOver="HM_f_PopUp('elMenu3',event)" onMouseOut="HM_f_PopDown('elMenu3')" onfocus="HM_f_PopUp('elMenu3',event)" onblur="HM_f_PopDown('elMenu3')" href="/senate/">Senate</a>&nbsp;&nbsp;</td>
            <td height="25" nowrap>&nbsp;&nbsp;<a class="mainmenu" onMouseOver="HM_f_PopUp('elMenu2',event)" onMouseOut="HM_f_PopDown('elMenu2')" onfocus="HM_f_PopUp('elMenu2',event)" onblur="HM_f_PopDown('elMenu2')" href="/house/">House</a>&nbsp;&nbsp;</td>
            <td height="25" nowrap>&nbsp;&nbsp;<a class="mainmenu" onMouseOver="HM_f_PopUp('elMenu4',event)" onMouseOut="HM_f_PopDown('elMenu4')" onfocus="HM_f_PopUp('elMenu4',event)" onblur="HM_f_PopDown('elMenu4')" href="/mylegislation/">My Legislation</a>&nbsp;&nbsp;</td>
            <td height="25" nowrap>&nbsp;&nbsp;<a class="mainmenu" href="/sitemap.asp">Site Map</a>&nbsp;&nbsp;</td>
            <td align="right" height="25" width="99%">
            &nbsp;
            </td>
          </tr>
        </table>
      </td>
    </tr>
    <tr>
     <td valign="top"><br>
<table class="sidemenu" border="0" width="140" cellpadding="0" cellspacing="2" id="Legislation"><tr><td class="sidemenu" nowrap ><b><a href="/legislation/default.asp" class="sidemenu">&nbsp;&nbsp;Bills & Resolutions&nbsp;&nbsp;</a></b></td></tr><tr><td class="sidemenu" nowrap ><a href="/legislation/ilcs/ilcs.asp" class="sidemenu">&nbsp;&nbsp;Compiled Statutes&nbsp;&nbsp;</a></td></tr><tr><td class="sidemenu" nowrap ><a href="/legislation/publicacts/default.asp" class="sidemenu">&nbsp;&nbsp;Public Acts&nbsp;&nbsp;</a></td></tr><tr><td class="sidemenu" nowrap ><a href="/reports/default.asp" class="sidemenu">&nbsp;&nbsp;Legislative Reports&nbsp;&nbsp;</a></td></tr><tr><td class="sidemenu" nowrap ><a href="/commission/lrb/conmain.htm" class="sidemenu">&nbsp;&nbsp;IL Constitution&nbsp;&nbsp;</a></td></tr><tr><td class="sidemenu" nowrap ><a href="/legislation/guide.asp" class="sidemenu">&nbsp;&nbsp;Legislative Guide&nbsp;&nbsp;</a></td></tr><tr><td class="sidemenu" nowrap ><a href="/legislation/glossary.asp" class="sidemenu">&nbsp;&nbsp;Legislative Glossary&nbsp;&nbsp;</a></td></tr><td class="sidemenu" nowrap width="90%"></td>
          
				
				<tr>
				<td class="black8ptbold"><br>&nbsp;Search By Number<br>&nbsp;(example: HB0001)</td>
			</tr>
			<tr>
				<td class="home">
				<form action="/numreslt.asp" method="post" id="NumString" name="NumString">
				<input NAME="NumSearch" TYPE="text" SIZE="10">
				<input NAME="cmdStatus" TYPE="submit" VALUE="Go">
				<!-- <input NAME="cmdHelp" TYPE="button" VALUE="Help" onclick="window.open('/num_look_help.htm','test','width=600,height=300')"> -->
				<a href="/num_look_help.htm" Target="SearchTips" title="Search Tips" onClick="window.open('/num_look_help.htm', 'SearchTips', 'width=600, height=300'); return false;">Search Tips</a><br><br>
				</form>
				</td>
			</tr>
			<tr>
				<td class="black8ptbold">Search By Keyword</td>
			</tr>
			<tr>
			<td class="home">
			<!-- <form name="searchForm" action="/search/iga_results.asp"> -->
			<script LANGUAGE="JAVASCRIPT">
			<!--
					

			//-->
			</script>
			<form name="searchForm" action="/search/iga_results.asp">
			<input type="text" name="q" size="10">
			<input type="submit" name="submit1" value="Go">
			<!-- <input type="button" name="cmdHelp1" value="Help" onclick="window.open('/search/searchhelp.htm','test','width=500,height=400,scrollbars')"> -->
			<!-- Next line's VALUE needs to change with each new General Assembly -->
			<input type="hidden" name="site" VALUE="leg101">
			
			<div>			
			<a href="/search/searchhelp.pdf" Target="SearchTips" title="Search Tips" onClick="window.open('/search/searchhelp.pdf', 'SearchTips'); return false;">Search Tips</a><br><br>
			<a href="/search/Advanced_Search.asp?site=leg101" title="Advanced Search">Advanced Search</a>
			<br><br>
			<!-- Amber alert and missing children --> 
			<a	href="http://www.amberillinois.com" >
				<img src="/images/amberillinois.jpg"
					width="80" height="60" border="0" 
					title="Illinois AMBER Alert" />
			</a>
			<br><br> 
			<a href="http://www.missingkids.com/">
				<img src="/images/missingexploited.jpg" 
					WIDTH="80" HEIGHT="60" border="0" 
					alt="Missing Kids" />
			</a>
			<!-- Amber alert and missing children --> 
			</form>
			</td>
		</tr>
          </tr></table></td><td width="1" class="verticalline"><img src="/images/1ptrans.gif" WIDTH="1" HEIGHT="1"></td><td valign="top" align="left" width="99%"><table align="left" border="0" width="490"><tr><td width="100%"><br>
<!-- End Body Start -->

<!--Begin Custom Page Content-->
<div><span class="heading">Full Text of HB0156&nbsp;&nbsp;</span><span class="italics">101st General Assembly</span></div><hr><div id="toplinks"><a href='fulltext.asp?DocName=10100HB0156&GA=101&SessionId=108&DocTypeId=HB&LegID=113980&DocNum=156&GAID=15&Session='>Introduced</a><a style="visibility: hidden" href='/legislation/101/HB/10100HB0156.htm'></a>&nbsp;&nbsp;<a href='fulltext.asp?DocName=10100HB0156eng&GA=101&SessionId=108&DocTypeId=HB&LegID=113980&DocNum=156&GAID=15&Session='>Engrossed</a><a style="visibility: hidden" href='/legislation/101/HB/10100HB0156eng.htm'></a><br><a href='fulltext.asp?DocName=10100HB0156ham001&GA=101&SessionId=108&DocTypeId=HB&LegID=113980&DocNum=156&GAID=15&Session='>House Amendment 001</a><a style="visibility: hidden" href='/legislation/101/HB/10100HB0156ham001.htm'></a><br><a href='/legislation/fulltext.asp?DocName=10100HB0156lv&SessionID=108&GA=101&DocTypeID=HB&DocNum=0156&print=true' target='_blank'>Printer-Friendly Version</a>&nbsp;&nbsp;<a style="visibility: hidden" href='/legislation/101/HB/10100HB0156lv.htm'></a><a href='/legislation/101/HB/PDF/10100HB0156lv.pdf'>PDF</a>&nbsp;&nbsp;<a href='/legislation/BillStatus.asp?DocNum=0156&GAID=15&DocTypeID=HB&LegID=113980&SessionID=108&SpecSess=&Session=&GA=101'>Bill Status</a></div><p><span class="notranslate"><!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"><html><head><style type="text/css">
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><title>HB0156eng 101ST GENERAL ASSEMBLY</title></head><body class="xsl"><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p>&nbsp;</p><br>&nbsp;</td></tr><code>
  </code><code>
  </code><code>
  </code></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br><code>
  </code></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>AN ACT concerning regulation.</code><code>
  </code><br>&nbsp;</td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><b><code>Be it enacted by the People of the State of Illinois,
 </code></b></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><b><code>represented in the General Assembly:</code></b><code>
  </code><code>
 </code><br>&nbsp;</td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 1. </code><code>Short title. </code><code>This Act may be cited as the </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Prescription Drug Pricing Transparency Act.</code><br>&nbsp;</td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 5. </code><code>Definitions. </code><code>In this Act:</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>"Department" means the Department of Public Health.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>"Manufacturer" means any entity that is engaged in the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>production, preparation, propagation, compounding, conversion, </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>or processing of prescription drugs, whether directly or </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>indirectly by extraction from substances of natural origin, </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>independently by means of chemical synthesis, or by a </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>combination of extraction and chemical synthesis, or any entity </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>engaged in the packaging, repackaging, labeling, relabeling, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>or distribution of prescription drugs. "Manufacturer" does not </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>include a wholesale distributor of prescription drugs, a </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>retailer, or a pharmacist licensed under the Pharmacy Practice </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>Act.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>"Prescription drug" means a drug as defined in 21 U.S.C. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>321.</code><br>&nbsp;</td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 10. </code><code>Disclosures to the Department. </code><code> </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(a) A health insurer shall disclose to the Department:</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(1) for all covered prescription drugs, including </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>generic drugs, brand-name drugs excluding specialty drugs, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>and specialty drugs dispensed at a pharmacy, network </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>pharmacy, or mail-order pharmacy for outpatient use:</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(A) the percentage of the premium rate </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>attributable to prescription drug costs for the prior </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>year for each category of prescription drugs;</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(B) the year-over-year increase or decrease, </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>expressed as a percentage, in per-member, per-month </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>total health plan spending on each category of </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>prescription drugs; and</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(C) the year-over-year increase or decrease in </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>per-member, per-month costs for prescription drugs </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>compared to other components of the premium rate; and</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(2) the specialty tier formulary list.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(b) The health insurer shall provide, if available, the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>percentage of the premium rate attributable to prescription </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>drugs administered by a health care provider in an outpatient </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>setting that are part of the medical benefit as separate from </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>the pharmacy benefit. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(c) The health insurer shall include information on its use </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>of a pharmacy benefit manager, if any, including which </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>components of the prescription drug coverage described in </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>subsections (a) and (b) are managed by the pharmacy benefit </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>manager, as well as the name of the pharmacy benefit manager or </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>pharmacy benefit managers used.</code><br>&nbsp;</td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 15. </code><code>Impact of prescription drug costs on health </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>insurance premiums; report. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(a) Each health insurer with more than 1,000 covered lives </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>in this State for major medical health insurance shall report </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>to the Department for all covered prescription drugs, including </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>generic drugs, brand-name drugs, and specialty drugs, provided </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>in an outpatient setting or sold in a retail setting:</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(1) the 25 most frequently prescribed drugs and the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>average wholesale price for each drug;</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(2) the 25 most costly drugs by total plan spending and </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the average wholesale price for each drug; and</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(3) the 25 drugs with the highest year-over-year price </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>increases and the average wholesale price for each drug.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(b) A health insurer shall not be required to provide to </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>the Department the actual price paid, net of rebates, for any </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>prescription drug.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(c) The Department shall compile the information reported </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>pursuant to subsection (a) into a consumer-friendly report that </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>demonstrates the overall impact of drug costs on health </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>insurance premiums. The data in the report shall be aggregated </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>and shall not reveal information specific to a particular </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>health benefit plan.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(d) The Department shall publish the report required </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>pursuant to subsection (a) on its website on or before January </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>1 of each year.</code><br>&nbsp;</td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 20. </code><code>Prescription drug cost transparency. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(a) The  Department shall  create annually  a list of 10 </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>prescription drugs on which the State spends significant health </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>care dollars and for which the wholesale acquisition cost has </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>increased by 50% or more over the past 5 years or by 15% or more  </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>during the previous calendar year, creating a substantial </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>public interest in understanding the development of the drugs' </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>pricing.  The list shall include at least one generic drug and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>one brand-name drug and shall indicate each of the drugs on the </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>list that the Department considers to be specialty drugs. The </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>Department shall include the percentage of the wholesale </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>acquisition cost increase for each drug on the list; rank the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>drugs on the list from those with the largest increase in </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>wholesale acquisition cost to those with the smallest increase; </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>indicate whether each drug was included on the list based on </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>its cost increase over the past 5 years or during the previous </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>calendar year, or both; and provide the State's total </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>expenditure for each drug on the list during the most recent </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>calendar year. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(b) The Department  shall create annually a list of 10 </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>prescription drugs on which the State spends significant health </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>care dollars and for which the cost to the State, net of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>rebates and other price concessions, has increased by 50% or </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>more over the past 5 years or by 15% or more during the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>previous calendar year, creating a substantial public interest </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>in understanding the development of the drugs' pricing. The </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>list shall include at least one generic drug and one brand-name </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>drug and shall indicate each of the drugs on the list that the </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>Department considers to be specialty drugs. The Department </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>shall rank the drugs on the list from those with the greatest </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>increase in net cost to those with the smallest increase and </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>indicate whether each drug was included on the list based on </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>its cost increase over the past 5 years or during the previous </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>calendar year, or both.</code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(c) Each health insurer with more than 5,000 covered lives </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>in this State for major medical health insurance shall create </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>annually a list of 10 prescription drugs on which its health </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>insurance plans spend significant amounts of their premium </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>dollars and for which the cost to the plans, net of rebates and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>other price concessions, has increased by 50% or more over the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>past 5 years or by 15% or more during the previous calendar </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>year, or both, creating a substantial public interest in </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>understanding the development of the drugs' pricing. The list </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>shall include at least one generic drug and one brand-name drug </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>and shall indicate each of the drugs on the list that the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>health insurer considers to be specialty drugs. The health </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>insurer shall rank the drugs on the list from those with the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>greatest increase in net cost to those with the smallest </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>increase and indicate whether each drug was included on the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>list based on its cost increase over the past 5 years or during </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>the previous calendar year, or both.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(d) Each health insurer creating a list pursuant to </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>subsection (c) shall provide to the Office of the Attorney </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>General the percentage by which the net cost to its plans </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>increased over the applicable period or periods for each drug </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>on the list, as well as the health insurer's total expenditure, </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>net of rebates and other price concessions, for each drug on </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>the list during the most recent calendar year. Information </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>provided to the Office of the Attorney General pursuant to this </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>subsection is exempt from public inspection and copying under </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>the Freedom of Information Act  and shall not be released.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(e) The  Department and the health insurers shall provide to </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>the Office of the Attorney General the  lists of prescription </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>drugs developed pursuant to subsections (a), (b), and (c)  </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>annually on or before June 1. The Office of the Attorney </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>General shall make all of the information available to the </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>public on  its website.</code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(f)  Of the prescription drugs listed by the Department and </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>the health insurers pursuant to  subsections (a), (b), and (c), </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>the Office of the Attorney General shall:</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(1) of the drugs appearing on more than one payer's </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>list, identify the top 15 drugs on which the greatest </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>amount of money was spent across all payers during the </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>previous calendar year, to the extent information is </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>available; and</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(2) if fewer than 15 drugs appear on more than one </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>payer's list, rank the remaining drugs based on the amount </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 7 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>of money spent by any one payer during the previous </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>calendar year, in descending order, and select as many of </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the drugs at the top of the list as necessary to reach a </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>total of 15 drugs.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(g) For the 15 drugs identified by the Office of the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>Attorney General pursuant to subsection (f), the Office of the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>Attorney General shall require the  manufacturer of each such </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>drug to provide  all of the following:</code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(1) justification for the increase in the  net cost of </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the drug to the Department, to one or more health insurers, </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>or both, which shall be provided to the Office of the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Attorney General in a format that the Office of the </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Attorney General determines to be understandable and </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>appropriate and shall be provided in accordance with a </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>timeline specified by the Office of the Attorney General; </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the manufacturer shall submit to the Office of the Attorney </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>General all relevant information and supporting </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>documentation necessary to justify the manufacturer's  net </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>cost increase  to the Department, to one or more health </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>insurers, or both during the identified period of time,  </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>including:</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(A)  each factor that specifically caused the net </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>cost increase  to the Department, to one or more health </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>insurers, or both during the specified period of time;</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(B) the percentage of the total  cost increase </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>attributable to each factor; and</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 8 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(C) an explanation of the role of each factor in </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<code>contributing to the  cost increase; and</code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(2) a separate version of the information submitted </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>pursuant to subparagraph (A) of paragraph (1), which shall </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>be made available to the public by the Office of the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Attorney General pursuant to subsection (i); if the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>manufacturer believes it necessary to redact certain </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>information in the public version as proprietary or </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>confidential, the manufacturer shall provide an </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>explanation for each such redaction to the Office of the </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Attorney General; the information, format, and any </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>redactions shall be subject to approval by the Office of </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the Attorney General; and</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(3) additional information in response to all requests </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>for such information by the Office of the Attorney General.</code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(h) Nothing in this Section shall be construed to restrict </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>the legal ability of a prescription drug manufacturer to change </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>prices to the extent permitted under federal law.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(i) The Attorney General shall provide a report to the </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>General Assembly on or before December 1 of each year based on </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>the information received from manufacturers pursuant to this </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>Section. The report to the General Assembly shall be filed with </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>the Clerk of the House of Representatives and the Secretary of </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>the Senate in electronic form only, in the manner that the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>Clerk and the Secretary shall direct. The Attorney General </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>shall  post the report and the public version of each </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 9 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>manufacturer's information submitted pursuant to paragraph (2) </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>of subsection (g) on the Office of the Attorney General's </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>website.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(j) The Department shall post on its website the report </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>prepared by the Attorney General pursuant to subsection (i) and </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>the public version of each manufacturer's information </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>submitted pursuant to paragraph (2) of subsection  (g) and may </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>inform the public of the availability of the report and the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>manufacturers' justification information. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(k) Information provided to the Office of the Attorney </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>General pursuant to subsection (g) is exempt from public </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>inspection and copying under the Freedom of Information  Act and </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>shall not be released in a manner that allows for the </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>identification of an individual drug or manufacturer or that is </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>likely to compromise the financial, competitive, or </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>proprietary nature of the information, except for the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>information prepared for release to the public pursuant to </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>paragraph (2) of subsection (g).</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(l) The Attorney General may bring an action in the circuit </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>court of Sangamon County  for injunctive relief, costs, and </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>attorney's fees and to impose on a manufacturer that fails to </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>provide any of the information required by subsections (f) and </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>(g), in the format requested by the Office of the Attorney </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>General and in accordance with the timeline specified by the </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>Office of the Attorney General, a civil penalty of  not more </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" ><code>than $10,000 per violation. Each unlawful failure to provide </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 10 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>information shall constitute a separate violation.</code><br>&nbsp;</td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 25. </code><code>Notice of introduction of new high-cost </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>prescription drugs.
</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(a) A manufacturer shall notify the Office of the Attorney </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>General in writing if it is introducing a new prescription drug </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>to market at a wholesale acquisition cost that exceeds the </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>threshold set for a specialty drug under the Medicare Part D </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>program. The manufacturer shall provide the written notice </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>within 3 calendar days following the release of the drug in the </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>commercial market. A manufacturer may make the notification </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>pending approval by the United States Food and Drug </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Administration if commercial availability is expected within 3 </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>calendar days following the approval.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(b) Not later than 30 calendar days following notification </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>pursuant to subsection (a), the manufacturer shall provide all </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>of the following information to the Office of the Attorney </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>General in a format that the Office of the Attorney General </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>prescribes:</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(1) a description of the marketing and pricing plans </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>used in the launch of the new drug in the United States and </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>internationally;</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(2) the estimated volume of patients who may be </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>prescribed the drug;</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(3) whether the drug was granted breakthrough therapy </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>designation or priority review by the United States Food </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 11 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>and Drug Administration prior to final approval; and</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(4) the date and price of acquisition if the drug was </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>not developed by the manufacturer.</code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(c) The manufacturer may limit the information reported </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>pursuant to subsection (b) to that which is otherwise in the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>public domain or publicly available.</code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(d) The Office of the Attorney General shall publish on its </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>website at least quarterly the information reported to it </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>pursuant to this Section. The information shall be published in </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>a manner that identifies the information that is disclosed on a </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>per-drug basis and shall not be aggregated in a manner that </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>would not allow identification of the drug.</code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(e) The Attorney General may bring an action in the circuit </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>court of Sangamon County for injunctive relief, costs, and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>attorney's fees and to impose on a manufacturer that fails to </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>provide the information required by subsection (b) a civil </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>penalty of not more than $1,000 per day for every day after the </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>notification period described in subsection (a) that the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>required information is not reported.</code><br>&nbsp;</td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 900. </code><code>The Freedom of Information Act is amended by </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>changing Section 7.5 as follows:</code><br>&nbsp;</td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(5 ILCS 140/7.5)</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Sec. 7.5. </code><code>Statutory exemptions. </code><code>To the extent provided for </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>by the statutes referenced below, the following shall be exempt </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 12 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>from inspection and copying:</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(a) All information determined to be confidential </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 4002 of the Technology Advancement and </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Development Act.</code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(b) Library circulation and order records identifying </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>library users with specific materials under the Library </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Records Confidentiality Act.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(c) Applications, related documents, and medical </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>records received by the Experimental Organ Transplantation </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Procedures Board and any and all documents or other records </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>prepared by the Experimental Organ Transplantation </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Procedures Board or its staff relating to applications it </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>has received.</code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(d) Information and records held by the Department of </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Public Health and its authorized representatives relating </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>to known or suspected cases of sexually transmissible </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>disease or any information the disclosure of which is </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>restricted under the Illinois Sexually Transmissible </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Disease Control Act.</code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(e) Information the disclosure of which is exempted </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 30 of the Radon Industry Licensing Act.</code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(f) Firm performance evaluations under Section 55 of </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the Architectural, Engineering, and Land Surveying </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Qualifications Based Selection Act.</code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(g) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>and exempted under Section 50 of the Illinois Prepaid </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 13 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Tuition Act.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(h) Information the disclosure of which is exempted </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under the State Officials and Employees Ethics Act, and </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>records of any lawfully created State or  local inspector </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>general's office that would be exempt if created or </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>obtained by an Executive Inspector General's office under </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>that Act.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(i) Information contained in a local emergency energy </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>plan submitted to a municipality in accordance with a local </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>emergency energy plan ordinance that is adopted under </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Section 11-21.5-5 of the Illinois Municipal Code.</code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(j) Information and data concerning the distribution </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>of surcharge moneys collected and remitted by carriers </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under the Emergency Telephone System Act.</code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(k) Law enforcement officer identification information </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>or driver identification information compiled by a law </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>enforcement agency or the Department of Transportation </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 11-212 of the Illinois Vehicle Code.</code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(l) Records and information provided to a residential </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>health care facility resident sexual assault and death </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>review team or the Executive Council under the Abuse </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Prevention Review Team Act.</code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(m) Information provided to the predatory lending </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>database created pursuant to Article 3 of the Residential </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Real Property Disclosure Act, except to the extent </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>authorized under that Article.</code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 14 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(n) Defense budgets and petitions for certification of </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>compensation and expenses for court appointed trial </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>counsel as provided under Sections 10 and 15 of the Capital </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Crimes Litigation Act. This subsection (n) shall apply </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>until the conclusion of the trial of the case, even if the </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>prosecution chooses not to pursue the death penalty prior </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>to trial or sentencing.</code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(o) Information that is prohibited from being </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>disclosed under Section 4 of the Illinois Health and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Hazardous Substances Registry Act.</code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(p) Security portions of system safety program plans, </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>investigation reports, surveys, schedules, lists, data, or </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>information compiled, collected, or prepared by or for the </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Regional Transportation Authority under Section 2.11 of </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the Regional Transportation Authority Act or the St. Clair </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>County Transit District under the Bi-State Transit Safety </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Act. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(q) Information prohibited from being disclosed by the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Personnel </code><u><code>Record</code></u><code> </code><strike><code>Records</code></strike><code> Review Act. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(r) Information prohibited from being disclosed by the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Illinois School Student Records Act. </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(s) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 5-108 of the Public Utilities Act. </code><code>
</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(t) All identified or deidentified health information </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>in the form of health data or medical records contained in, </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>stored in, submitted to, transferred by, or released from </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 15 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the Illinois Health Information Exchange, and identified </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>or deidentified health information in the form of  health </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>data and medical records of the Illinois Health Information </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Exchange  in the possession of the Illinois Health </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Information Exchange Authority due to its administration </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>of the Illinois Health Information Exchange. The terms </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>"identified" and "deidentified" shall be given the same </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>meaning as in the Health Insurance Portability and </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Accountability Act of 1996, Public Law 104-191, or any </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>subsequent amendments thereto, and any regulations </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>promulgated thereunder. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(u) Records and information provided to an independent </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>team of experts under </code><u><code>the Developmental Disability and </code></u></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<u><code>Mental Health Safety Act (also known as</code></u><code> Brian's Law</code><u><code>)</code></u><code>. </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(v) Names and information of people who have applied </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>for or received Firearm Owner's Identification Cards under </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the Firearm Owners Identification Card Act or applied for </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>or received a concealed carry license under the Firearm </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Concealed Carry Act, unless otherwise authorized by the </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Firearm Concealed Carry Act; and databases under the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Firearm Concealed Carry Act, records of the Concealed Carry </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Licensing Review Board under the Firearm Concealed Carry </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Act, and law enforcement agency objections under the </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Firearm Concealed Carry Act. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(w) Personally identifiable information which is </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>exempted from disclosure under subsection (g) of Section </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 16 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>19.1 of the Toll Highway Act.</code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(x) Information which is exempted from disclosure </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 5-1014.3 of the Counties Code or Section </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>8-11-21 of the Illinois Municipal Code. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(y) Confidential information under the Adult </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Protective Services Act and its predecessor enabling </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>statute, the Elder Abuse and Neglect Act, including </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>information about the identity and administrative finding </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>against any caregiver of a verified and substantiated </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>decision of abuse, neglect, or financial exploitation of an </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>eligible adult maintained in the Registry established </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 7.5 of the Adult Protective Services Act. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(z) Records and information provided to a fatality </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>review team or the Illinois Fatality Review Team Advisory </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Council under Section 15 of the Adult Protective Services </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Act. </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(aa) Information which is exempted from disclosure </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 2.37 of the Wildlife Code. </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(bb) Information which is or was prohibited from </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>disclosure by the Juvenile Court Act of 1987. </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(cc) Recordings made under the Law Enforcement </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Officer-Worn Body Camera Act, except to the extent </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>authorized under that Act.</code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(dd) Information that is prohibited from being </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>disclosed under Section 45 of the Condominium and Common </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Interest Community Ombudsperson Act. </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 17 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(ee) Information that is exempted from disclosure </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 30.1 of the Pharmacy Practice Act. </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(ff) Information that is exempted from disclosure </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under the Revised Uniform Unclaimed Property Act. </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(gg) Information that is prohibited from being </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>disclosed under Section 7-603.5 of the Illinois Vehicle </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Code. </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(hh) Records that are exempt from disclosure under </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Section 1A-16.7 of the Election Code. </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(ii) Information which is exempted from disclosure </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 2505-800 of the Department of Revenue Law of </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>the Civil Administrative Code of Illinois. </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(jj) Information and reports that are required to be </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>submitted to the Department of Labor by registering day and </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>temporary labor service agencies but are exempt from </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>disclosure under subsection (a-1) of Section 45 of the Day </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>and Temporary Labor Services Act. </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(kk) Information prohibited from disclosure under the </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Seizure and Forfeiture Reporting Act. </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>(ll) Information the disclosure of which is restricted </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>and exempted under Section 5-30.8 of the Illinois Public </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Aid Code. </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><u><code>(mm)</code></u><code> </code><strike><code>(ll)</code></strike><code> Records that are exempt from disclosure under </code></td></tr><tr><td class="number">24</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Section 4.2 of the Crime Victims Compensation Act. </code></td></tr><tr><td class="number">25</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><u><code>(nn)</code></u><code> </code><strike><code>(ll)</code></strike><code> Information that is exempt from disclosure </code></td></tr><tr><td class="number">26</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>under Section 70 of the Higher Education Student Assistance </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 18 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<code>Act. </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><u><code>(oo) Information provided to the Office of the Attorney </code></u></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<u><code>General under subsections (d) and (g) of Section 20   of the </code></u></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<u><code>Prescription Drug Pricing Transparency Act, except for the </code></u></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<u><code>information prepared for release to the public pursuant to </code></u></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<u><code>paragraph (2) of subsection (g) of Section 20 of the </code></u></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" >&nbsp;&nbsp;&nbsp;&nbsp;<u><code>Prescription Drug Pricing Transparency Act.</code></u><code> </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>(Source: P.A. 99-78, eff. 7-20-15; 99-298, eff. 8-6-15; 99-352, </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>eff. 1-1-16; 99-642, eff. 7-28-16; 99-776, eff. 8-12-16; </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>99-863, eff. 8-19-16; 100-20, eff. 7-1-17; 100-22, eff. 1-1-18; </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>100-201, eff. 8-18-17; 100-373, eff. 1-1-18; 100-464, eff. </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>8-28-17; 100-465, eff. 8-31-17; 100-512, eff. 7-1-18; 100-517, </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>eff. 6-1-18; 100-646, eff. 7-27-18; 100-690, eff. 1-1-19; </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>100-863, eff. 8-14-18; 100-887, eff. 8-14-18; revised </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>10-12-18.)</code><br>&nbsp;<code>
 </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>Section 999. </code><code>Effective date. </code><code>This Act takes effect upon </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>becoming law.</code><code> </code><code>
  </code><code>
</code></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="45%"></colgroup><colgroup width="45%"></colgroup></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="4"><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td class="xsl" colspan="4"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HB0156 Engrossed</td><td class="xsl" align="center">- 19 -</td><td class="xsl" align="right">LRB101 03973 SMS 48981 b</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" colspan="4" align="center">
									INDEX
								</td></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" colspan="2" align="center">
									Statutes amended in order of appearance
								</td><tr><td class="xsl"></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>New Act</code></td><td class="xsl"></td></tr><tr><td class="xsl"></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>5 ILCS 140/7.5</code></td><td class="xsl"></td></tr><tr><td class="xsl"></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>215 ILCS 5/356z.33 new</code></td><td class="xsl"></td></tr><tr><td class="xsl"></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>225 ILCS 85/16d new</code></td><td class="xsl"></td></tr><tr><td class="xsl"></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>225 ILCS 85/19.5</code></td><td class="xsl"></td></tr><tr><td class="xsl"></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>225 ILCS 85/19.7 new</code></td><td class="xsl"></td></tr><tr><code> </code><td class="xsl"></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>225 ILCS 85/25</code></td><td class="xsl"><code>from Ch. 111, par. 4145</code></td><code> </code></tr><tr><td class="xsl"></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>&nbsp;&nbsp;&nbsp;&nbsp;</code><code>225 ILCS 85/41</code></td><td class="xsl"></td></tr></table></td ></tr><tr><td class="xsl"></pre></table></body></html></span>
<!--End Custom Page Content-->

<!--Begin Page End-->


</td></tr>
<tr id="Legislation">
<td>
  <table border="0" class="footer" cellspacing="0" cellpadding="0" align="center" width="100%">
    <tr>
      <td align="center" colspan="2"><hr noShade="True" color="navy">
      <a class="footer" href="/" title="View the General Assembly web site home page">Home</a> | 
      <a class="footer" href="/legislation/" title="View Legislation and Laws">Legislation &amp; Laws</a> | 
      <a class="footer" href="/house/default.asp" title="View information regarding House of Representatives">House</a> | 
      <a class="footer" href="/senate/default.asp" title="View information regarding Senate">Senate</a> |
      <a class="footer" href="/mylegislation/default.asp" title="Set up customized queries, create reports for tracking, etc.">My Legislation</a> |
      <a class="footer" href="/disclaimer.asp" title="Disclaimers regarding the Illinois General Assembly web site">Disclaimers</a> |
      <a class="footer" href="/contact.asp" title="Contact the Illinois General Assembly Web Support Staff">Email</a>
      </td>
    </tr>
    <tr>
		<td align="center" colspan="2"><hr noShade="True" color="navy"><br></td>
    </tr>
    <tr>
		<td align="left" class="footer" width="107">&nbsp;&nbsp;<img src="/images/lislogo.jpg" alt="Legislative Information System logo" width="100" height="45"></td>
		<td align+"left" valign="top" class="footer" width="100%">This site is maintained for the Illinois General Assembly 
by the<br>Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706<br> 
217-782-3944&nbsp;&nbsp;&nbsp;217-782-2050&nbsp;(TTY) 
<br>
		</td>
	</tr>
  </table>
    
</td>
</tr>
</table>
<p>&nbsp;</p><br>
</td>
</tr>
</table>
</body>  
</html>

<!--End Page End-->
